KASEY JOHNSON: Open Payments
NPI 1417609603 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 63 payments from 13 companies in 2025. Trend: 2023 $1,386 · 2024 $1,106 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $242 |
| GlaxoSmithKline, LLC. | 13 | $232 |
| Novo Nordisk Inc | 12 | $213 |
| Lilly USA, LLC | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| ABBVIE INC. | 3 | $61 |
| PFIZER INC. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: TRELEGY ELLIPTA, OTEZLA, Wegovy, EVENITY, MOUNJARO, UBRELVY, LEQVIO, ELIQUIS.
Industry payments across NC — which companies pay providers there.
